FunPep Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:FunPep Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11107
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
FunPep Co Ltd (FunPep) is a biotechnology venture company that focuses on the development of peptides. The company’s pipeline products include SR-0379 functional peptide and FPP003 antibody inducing peptide. It uses smart peptide research integrated technology for developing functional peptides and search technology of epitope for unique peptide vaccine for developing antibody-inducing peptides. FunPep’s SR-0379 is an intractable skin ulcer drug that promotes wound healing functions such as granulation tissue formation and remodeling. The company’s functional peptides find applications in pharmaceutical, cosmetic, and medical device companies. It has operations in Tokyo and Osaka, Japan. FunPep is headquartered in Tokyo, Japan.

FunPep Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FunPep Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
FunPep Raises USD4 Million in Venture Financing 10
Partnerships 11
FunPep Enters into Research Agreement with Fujifilm 11
FunPep Enters into Research Agreement with Shionogi 12
FunPep Enters into Research Agreement with Sumitomo Dainippon 13
Licensing Agreements 14
FunPep Enters into License Agreement with Medipal Holdings 14
Shionogi Enters into Licensing Agreement with FunPep 15
FunPep Enters into Licensing Agreement with Osaka University 16
FunPep Co Ltd – Key Competitors 17
FunPep Co Ltd – Key Employees 18
FunPep Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
FunPep Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FunPep Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FunPep Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
FunPep Raises USD4 Million in Venture Financing 10
FunPep Enters into Research Agreement with Fujifilm 11
FunPep Enters into Research Agreement with Shionogi 12
FunPep Enters into Research Agreement with Sumitomo Dainippon 13
FunPep Enters into License Agreement with Medipal Holdings 14
Shionogi Enters into Licensing Agreement with FunPep 15
FunPep Enters into Licensing Agreement with Osaka University 16
FunPep Co Ltd, Key Competitors 17
FunPep Co Ltd, Key Employees 18
FunPep Co Ltd, Other Locations 19

List of Figures
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[FunPep Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oil and Natural Gas Corporation Ltd (ONGC)-石油・ガス分野:企業M&A・提携分析
    Summary Oil and Natural Gas Corporation Ltd (ONGC) is an integrated oil and gas company. It explores for and produces oil and natural gas; refines crude oil; and markets and distributes petroleum products. The company's product portfolio includes crude oil, natural gas, liquefied natural gas, naphth …
  • EnBW Energie Baden-Wuerttenberg AG:戦略・SWOT・企業財務分析
    EnBW Energie Baden-Wuerttenberg AG - Strategy, SWOT and Corporate Finance Report Summary EnBW Energie Baden-Wuerttenberg AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Xylem Inc (XYL):石油・ガス:M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …
  • DST Systems, Inc.:企業の戦略・SWOT・財務情報
    DST Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary DST Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Tourism Holdings Limited:企業の戦略・SWOT・財務分析
    Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CellaVision AB (CEVI):医療機器:M&Aディール及び事業提携情報
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • Cook Medical Inc:企業の戦略的SWOT分析
    Cook Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Woodside Petroleum Ltd (WPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of facilities in association with some of the world’s major oil and gas companies. The company operates liquefi …
  • Intrinsic Therapeutics Inc-医療機器分野:企業M&A・提携分析
    Summary Intrinsic Therapeutics Inc (Intrinsic) is a medical device company that develops medical devices for the treatment of lumbar disc herniations. The company offers prosthesis for partial anulus replacement following discectomy surgery; prosthesis for partial anulus replacement; and anular clos …
  • Lakes Oil NL (LKO):石油・ガス:M&Aディール及び事業提携情報
    Summary Lakes Oil NL (Lake Oil) is an upstream company that carries out exploration and production oil and gas. The company acquires, explores, and develops oil and natural gas properties. It operates Gippsland basin and Otway basin in Australia. Lake Oil offers re-processing and re-mapping of avail …
  • Berthold Technologies GmbH & Co. KG:企業の戦略的SWOT分析
    Berthold Technologies GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • ProThera Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ProThera Biologics Inc (ProThera), formerly ProThera Biologics LLC is a biotherapeutics company that develops novel products based on Inter-alpha Inhibitor Proteins. The company offers development of commercial potential of IAIP for treating acute, life-threatening inflammatory diseases. Pro …
  • Garfunkelux Holdco 2 SA:企業の戦略的SWOT分析
    Garfunkelux Holdco 2 SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Handok Inc (002390)-製薬・医療分野:企業M&A・提携分析
    Summary Handok Inc (Handok), formerly known as Handok Pharmaceuticals Co Ltd, is a pharmaceutical and health care company which develops, manufactures and distributes healthcare solutions. The company develops and provides pharmaceutical products including prescription drugs, OTC drugs, medical devi …
  • Miracor Medical Systems GmbH-医療機器分野:企業M&A・提携分析
    Summary Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and imp …
  • Southern Maryland Electric Cooperative Inc:発電所・企業SWOT分析
    Southern Maryland Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, infor …
  • Stereotaxis Inc (STXS)-製薬・医療分野:企業M&A・提携分析
    Summary Stereotaxis Inc (Stereotaxis) is a healthcare technology company that designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch Solution is an advanced remote robotic navigation system for …
  • Cheetah Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cheetah Medical Inc (Cheetah Medical) is a provider of non-invasive hemodynamic monitoring technologies. The company provides products such as Cheetah Nicom prewired sensors and Starling SV systems. It also provides Starling SV system accessories such as monitors and sensors, replacement par …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆